Page 178 Acute Pain Management
P. 178




The
addition
of
intra‐articular
sufentanil
to
a
mixture
of
ropivacaine
and
clonidine
following

anterior
cruciate
ligament
repair
provided
no
additional
analgesic
benefits
(Armellin
et
al,
2008

Level
II).
A
mixture
of
intra‐articular
bupivacaine
and
100
mg
tramadol
resulted
in
better
pain

relief
and
lower
rescue
analgesic
requirements
than
use
of
either
drug
alone
(Zeidan
et
al,

2008
Level
II).

There
is
no
evidence
for
analgesic
efficacy
of
peripheral
opioids
at
non‐intra‐articular
sites,

including
use
with
perineural
blockade
(Picard
et
al,
1997
Level
I).
While
opioid
receptors
have

been
identified
in
the
cornea
and
skin,
topically
applied
opioids
have
not
consistently

demonstrated
efficacy
in
pain
states
such
as
corneal
ulceration
(fentanyl)
(Zollner
et
al,
2008

Level
II),
partial
thickness
burns
(morphine)
(Welling,
2007
Level
II),
or
chronic
skin
ulceration

(morphine)
(Vernassiere
et
al,
2005
Level
II).

Although
commonly
used,
oral
morphine
mouthwash
in
chemotherapy‐induced
mucositis
pain

has
only
limited
supporting
evidence;
a
dose‐response
(beneficial)
effect
was
seen
in
a
small

pilot
study
using
1
mg/mL
and
2
mg/mL
morphine
mouthwash
(Cerchietti
et
al,
2003
Level
II).

Benefit
was
also
evident
in
a
small
comparison
of
morphine
mouthwash
30
mg
3‐hourly,
with

a
local
anaesthetic‐based
solution,
in
mucositis
associated
with
chemoradiotherapy
in
head

and
neck
cancer
patients
(Cerchietti
et
al,
2002
Level
II).


Key
messages

1.
 Intrathecal
morphine
produces
better
postoperative
analgesia
than
intrathecal
fentanyl

after
Caesarean
section
(U)
(Level
I).

CHAPTER
5
 2.
 Intrathecal
morphine
doses
of
300
mcg
or
more
increase
the
risk
of
respiratory
depression

(N)
(Level
I).



3.
 Morphine
injected
into
the
intra‐articular
space
following
knee
arthroscopy
does
not

improve
analgesia
compared
with
placebo
when
administered
after
surgery
(R)
(Level
I).

4.
 Evidence
for
a
clinically
relevant
peripheral
opioid
effect
at
non‐articular
sites,
including

perineural,
is
inconclusive
(U)
(Level
I).

5.
 Epidural
pethidine
produces
better
pain
relief
and
less
sedation
than
IV
pethidine
after

Caesarean
section
(U)
(Level
II).

6.
 Extended
release
epidural
morphine
provides
analgesia
for
up
to
48
hours,
however

central
depressant
effects,
including
respiratory
depression,
may
also
be
increased
and

prolonged
(N)
(Level
II).


The
following
tick
boxes

represent
conclusions
based
on
clinical
experience
and
expert

opinion.

 No
neurotoxicity
has
been
shown
at
normal
clinical
intrathecal
doses
of
morphine,
fentanyl

and
sufentanil
(U).

 Neuraxial
administration
of
bolus
doses
of
hydrophilic
opioids
carries
an
increased
risk
of

delayed
sedation
and
respiratory
depression
compared
with
lipophilic
opioids
(U).














130
 Acute
Pain
Management:
Scientific
Evidence

   173   174   175   176   177   178   179   180   181   182   183